US biotechnology market is estimated to grow significantly at a CAGR of 7.4% during the forecast period. The US biotechnology industry was valued at $200 billion in 2019 and anticpated to grow significantly during the forecast period. This growth is backed by the advanced and well-developed healthcare infrastructure which homes several research institutes mainly focusing on stem cell research. Research institutes strive to develop innovative and advanced techniques to cure diseases including diabetes and cancer. Moreover, there are a range of stem cell research institute in the country that has started focusing on carrying research with cell harvesting procedures. The US is the largest investor in public research funding, and it continues to increase its investment to maintain its position at the global level. Moreover, Large-scale integrated programs are being funded by government agencies such as the NSF and DARPA to innovate solutions for sustainable development. It is anticipated that with the sustainable strategic investment from the US government agencies, biotechnology will continue to thrive in both, basic and applied research in the US.

Visit for Global Biotechnology Market Report at: https://www.omrglobal.com/industry-reports/biotechnology-market

US biotechnology market is classified on the basis of type. Based on type, the market is segmented into healthcare, crop production and agriculture, industrial, natural resources & environment, and others. The companies which are contributing to the growth of the US biotechnology industry include Amgen Inc., Novo Nordisk A/S, CSL Ltd., Bristol-Myers Squibb Co., AstraZeneca PLC, Merck & Co., Inc., Johnson & Johnson Services Inc., and Pfizer Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. 

Research Methodology

The market study of the US biotechnology market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

The Report Covers

• Comprehensive research methodology of the US biotechnology market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US biotechnology market.
• Insights about market determinants which are stimulating the US biotechnology market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.